Skip to main content
Gilead to invest $5.1B in investment deal with Belgium-based Galapagos
7/15/2019

Gilead Sciences announced plans to invest $5.1 billion to increase its stake in Dutch biotech firm Galapagos, with an upfront payment of $3.95 billion and an investment of $1.1 billion to be made by Gilead, while the partners will develop and market treatments for a decade. Galapagos needs to ask for shareholder approval prior to allowing Gilead to raise its ownership stake further.

Full Story: